Drugplain

Insulin Aspart 100 [iU]/mL

insulin aspart · INJECTION, SOLUTION · REMEDYREPACK INC.

No Recall HistoryCurrently in Shortage
Plain English

Insulin Aspart is a injection, solution containing insulin aspart at 100 [iU]/mL, taken intravenous. Manufactured by REMEDYREPACK INC..

Key Facts

Brand Name
Insulin Aspart
Generic Name
insulin aspart
NDC Code (Product)
70518-3865
Manufacturer
REMEDYREPACK INC.
Strength
100 [iU]/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Marketing Status
Application #
BLA020986
Drug Class
Insulin Analog [EPC]
Marketing Start
09/18/2023

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dyspnoea655 reports
nausea615 reports
hypoglycaemia567 reports
vomiting560 reports
blood glucose increased557 reports
off label use534 reports
abdominal pain449 reports
condition aggravated430 reports
diarrhoea421 reports
acute kidney injury417 reports

Frequently Asked Questions

What is Insulin Aspart used for?

Insulin Aspart contains insulin aspart. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is Insulin Aspart a controlled substance?

Insulin Aspart is not classified as a controlled substance by the DEA.

What is the generic name for Insulin Aspart?

The generic name for Insulin Aspart is insulin aspart. There are 10 other brand versions of insulin aspart.

What is the NDC code for Insulin Aspart 100 [iU]/mL?

The NDC (National Drug Code) for Insulin Aspart 100 [iU]/mL is 70518-3865, listed by REMEDYREPACK INC..

Product NDC

70518-3865

Package NDC

70518-3865-0

Other Insulin Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)